CN105341641A - Health-care flour capable of reducing blood sugar and preparation method of health-care flour - Google Patents
Health-care flour capable of reducing blood sugar and preparation method of health-care flour Download PDFInfo
- Publication number
- CN105341641A CN105341641A CN201510628790.2A CN201510628790A CN105341641A CN 105341641 A CN105341641 A CN 105341641A CN 201510628790 A CN201510628790 A CN 201510628790A CN 105341641 A CN105341641 A CN 105341641A
- Authority
- CN
- China
- Prior art keywords
- flour
- parts
- konjac
- powder
- arabinose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013312 flour Nutrition 0.000 title claims abstract description 172
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000008280 blood Substances 0.000 title abstract description 16
- 210000004369 blood Anatomy 0.000 title abstract description 16
- 244000247812 Amorphophallus rivieri Species 0.000 claims abstract description 39
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims abstract description 39
- 229920002752 Konjac Polymers 0.000 claims abstract description 39
- 239000000252 konjac Substances 0.000 claims abstract description 39
- 235000010485 konjac Nutrition 0.000 claims abstract description 39
- 239000000843 powder Substances 0.000 claims abstract description 39
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 29
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 26
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229920000157 polyfructose Polymers 0.000 claims abstract description 25
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 23
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 20
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 20
- 241000209140 Triticum Species 0.000 claims abstract description 11
- 235000021307 Triticum Nutrition 0.000 claims abstract description 11
- 241000219051 Fagopyrum Species 0.000 claims abstract 6
- 235000013339 cereals Nutrition 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 5
- 230000032683 aging Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims 1
- 229920002472 Starch Polymers 0.000 abstract description 12
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 12
- 239000008107 starch Substances 0.000 abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 11
- 239000008103 glucose Substances 0.000 abstract description 11
- 235000019698 starch Nutrition 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 210000000813 small intestine Anatomy 0.000 abstract description 5
- 150000001720 carbohydrates Chemical class 0.000 abstract description 4
- 235000014633 carbohydrates Nutrition 0.000 abstract description 4
- 230000007062 hydrolysis Effects 0.000 abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 4
- 230000000291 postprandial effect Effects 0.000 abstract description 4
- 102000004877 Insulin Human genes 0.000 abstract description 3
- 108090001061 Insulin Proteins 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 229940125396 insulin Drugs 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 230000008855 peristalsis Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 17
- 238000003756 stirring Methods 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000000832 Ayote Nutrition 0.000 description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 description 3
- 240000001980 Cucurbita pepo Species 0.000 description 3
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000015136 pumpkin Nutrition 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 240000005717 Dioscorea alata Species 0.000 description 2
- 235000002723 Dioscorea alata Nutrition 0.000 description 2
- 235000007056 Dioscorea composita Nutrition 0.000 description 2
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 2
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 2
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 2
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 2
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 2
- 241000893536 Epimedium Species 0.000 description 2
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 2
- 241000405911 Rehmannia glutinosa Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 235000018905 epimedium Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical class CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000010804 Maranta arundinacea Nutrition 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241001633680 Polygonatum odoratum Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 244000145580 Thalia geniculata Species 0.000 description 1
- 235000012419 Thalia geniculata Nutrition 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229960004329 metformin hydrochloride Drugs 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种降糖保健面粉及其制备方法。该面粉主要由以下质量份的组分组成:小麦粉80~95份,燕麦粉8~15份,荞麦粉4~6份,多聚果糖3~6份,L-阿拉伯糖2~4份,魔芋粉0.5~1.5份。该面粉产品口感好,安全性高,还能提供一定的能量,所添加的燕麦粉、苦荞麦粉、多聚果糖、L-阿拉伯糖和魔芋纯化粉在降血糖方面具有相互协同效应和倍增效果,从提高葡萄糖耐量,增强胰岛素的功能,抑制淀粉转变成葡萄糖,延缓人体小肠壁对糖类的吸收速率,促进肠道蠕动、减慢淀粉的水解速度等多个方面降低糖尿病患者餐后血糖水平,减少高血糖对其身体造成的伤害。The invention discloses a hypoglycemic health-care flour and a preparation method thereof. The flour is mainly composed of the following components by mass: 80-95 parts of wheat flour, 8-15 parts of oat flour, 4-6 parts of buckwheat flour, 3-6 parts of polyfructose, 2-4 parts of L-arabinose, konjac Powder 0.5 ~ 1.5 parts. The flour product has a good taste, high safety, and can also provide a certain amount of energy. The added oat flour, tartary buckwheat flour, polyfructose, L-arabinose and konjac purified powder have mutual synergistic and multiplied effects in reducing blood sugar , from improving glucose tolerance, enhancing insulin function, inhibiting the conversion of starch into glucose, delaying the absorption rate of carbohydrates by the human small intestine wall, promoting intestinal peristalsis, slowing down the hydrolysis rate of starch and other aspects to reduce the postprandial blood sugar level of diabetic patients , Reduce the damage caused by high blood sugar to its body.
Description
技术领域technical field
本发明属于食品制备技术领域,具体涉及一种降糖保健面粉及其制备方法。The invention belongs to the technical field of food preparation, and in particular relates to a hypoglycemic health-care flour and a preparation method thereof.
背景技术Background technique
随着生活水平的提高,人们的饮食结构发生了重大变化,已由过去以“高谷物膳食”类型转变为“三高”类型(高蛋白、高脂肪和高热能),由此带来了各种慢性疾病流行,如糖尿病、心血管疾病、肠道疾病、肥胖病等。糖尿病在全球发病率为3%~5%,我国更为严重,据2013年统计已超过1.2亿人,主要原因之一是人们在饮食中上追求精、细,如各类精制面粉。这类面粉由于其外观白,口感好,加工性能好和产品品质高,深受人们喜爱,但这类面粉更易引起餐后血糖的升高,增加患糖尿病的风险,也会严重损害患者的身体健康。现有技术也出现了多种针对糖尿病患者的降血糖面粉。With the improvement of living standards, major changes have taken place in people's diet structure, which has changed from "high grain diet" type to "three high" type (high protein, high fat and high energy), which has brought various The prevalence of various chronic diseases, such as diabetes, cardiovascular disease, intestinal disease, obesity, etc. The incidence of diabetes in the world is 3% to 5%, and it is more serious in my country. According to statistics in 2013, there are more than 120 million people. One of the main reasons is that people pursue fine and fine food, such as various refined flour. This kind of flour is very popular because of its white appearance, good taste, good processing performance and high product quality. However, this kind of flour is more likely to cause postprandial blood sugar rise, increase the risk of diabetes, and seriously damage the patient's body healthy. The prior art also has multiple hypoglycemic flours for diabetics.
CN102960387A公开了一种用于糖尿病人的保健面粉,这种面粉由荞麦、小麦、黄豆、山药、葛粉、茯苓粉、黄芪组成;CN102715208B公开了一种营养强化降血糖苦瓜面粉,该面粉由下述原料制得:小麦、小麦胚芽、南瓜花、绿豆粉、百合、苦瓜、山药、葛根、决明子、党参花粉、黄芪、南瓜和人参提取物;CN103371323A公开了一种魔芋大豆降血糖面粉及其制备方法,该降血糖面粉由面粉、魔芋、大豆、玉米须、麦麸、南瓜、丁香叶、地黄、荞麦根、生姜、淫羊藿、桑葚、党参、大蓟、草莓叶组成。CN102960387A discloses a kind of health-care flour for diabetic patients, which is composed of buckwheat, wheat, soybean, yam, arrowroot powder, poria powder, and astragalus; Raw materials: wheat, wheat germ, pumpkin flower, mung bean powder, lily, bitter gourd, yam, kudzu root, cassia seed, codonopsis pollen, astragalus, pumpkin and ginseng extract; CN103371323A discloses a konjac soybean hypoglycemic flour and its preparation method The hypoglycemic flour is composed of flour, konjac, soybean, corn silk, wheat bran, pumpkin, clove leaf, rehmannia glutinosa, buckwheat root, ginger, epimedium, mulberry, Codonopsis pilosula, thistle and strawberry leaf.
上述降血糖面粉往往添加了各种中药材原料,如葛根、黄芪、决明子、人参提取物、地黄、淫羊藿、党参等,虽然具有一定的将血糖功效,但由于所添加的中药材气味不好,加工性能差,所制得的产品口感不好,质量不佳,而且一些中药材还有一定的副作用,对人体造成不良影响。The above-mentioned hypoglycemic flour is often added with various Chinese medicinal materials, such as pueraria root, astragalus root, cassia seed, ginseng extract, rehmannia glutinosa, epimedium, codonopsis, etc. Although it has a certain effect of lowering blood sugar, the smell of the added Chinese medicinal materials is not However, the processing performance is poor, the taste of the prepared product is not good, the quality is not good, and some Chinese medicinal materials also have certain side effects, which cause adverse effects on the human body.
CN103829140A公开了一种谷物粉,由全麦粉、燕麦粉、荞麦粉、魔芋粉、脱水木耳粉、脱水芹菜粉、低聚果糖、沙棘提取物、玉竹提取物、鹌鹑肉颗粒、海虾粉、鲜玉米粉、胡萝卜颗粒、水组成。该谷物粉虽不含中药材,但并不适宜作为日常面粉经常食用,且谷物粉中的淀粉含量低,很难满足糖尿病人日常能量的需求,在一定程度上限制了其实际应用。CN103829140A discloses a kind of grain flour, which is composed of whole wheat flour, oat flour, buckwheat flour, konjac flour, dehydrated fungus powder, dehydrated celery powder, fructooligosaccharides, seabuckthorn extract, Polygonatum odoratum extract, quail meat particles, sea shrimp powder, Composed of fresh corn flour, carrot granules, and water. Although the grain flour does not contain Chinese medicinal materials, it is not suitable for regular consumption as daily flour, and the starch content in the grain flour is low, so it is difficult to meet the daily energy needs of diabetics, which limits its practical application to a certain extent.
发明内容Contents of the invention
本发明的目的是提供一种降糖保健面粉,从而解决现有技术中,降血糖面粉多含有中药组分或面粉含量过低,而造成的食品口感、安全和能量供给难以得到保证的问题,同时可以辅助降低糖尿病患者餐后血糖的水平,减少高血糖对身体造成的伤害。The purpose of the present invention is to provide a hypoglycemic health-care flour, thereby solving the problems in the prior art that the hypoglycemic flour mostly contains traditional Chinese medicine components or the content of the flour is too low, which makes it difficult to guarantee food taste, safety and energy supply. At the same time, it can help to reduce the postprandial blood sugar level of diabetic patients and reduce the damage caused by high blood sugar to the body.
本发明的第二个目的是提供上述面粉的制备方法。The second object of the present invention is to provide a method for preparing the above-mentioned flour.
为了实现以上目的,本发明所采用的技术方案是:In order to achieve the above object, the technical solution adopted in the present invention is:
一种降糖保健面粉,主要由以下质量份的组分组成:小麦粉80~95份,燕麦粉8~15份,荞麦粉4~6份,多聚果糖3~6份,L-阿拉伯糖2~4份,魔芋粉0.5~1.5份。A hypoglycemic health-care flour, mainly composed of the following components by mass: 80-95 parts of wheat flour, 8-15 parts of oat flour, 4-6 parts of buckwheat flour, 3-6 parts of polyfructose, 2 parts of L-arabinose ~4 parts, konjac flour 0.5~1.5 parts.
本发明提供的降糖保健面粉,以常规面粉为载体,配以燕麦粉、荞麦粉、魔芋粉的杂粮成分,再辅以多聚果糖和L-阿拉伯糖组分,使得到的降血糖面粉口感好,安全性高,还能提供一定的能量。该面粉中,燕麦粉中富含可溶性β-葡聚糖,具有提高葡萄糖耐量和降低α-淀粉酶水解淀粉程度的作用;它能将淀粉分子包裹起来,影响蛋白-淀粉基质的结构,降低了淀粉水解酶类与淀粉底物分子之间的作用;荞麦粉中含有一定量的抗性淀粉,这种淀粉不被小肠吸收,而在大肠中发酵,使得葡萄糖缓慢释放;其Cr3+含量丰富,构成葡萄糖耐量因子,可增强胰岛素的功能;同时,荞麦组分还可起到葡萄糖苷酶抑制剂的作用,其组成中含有一定量的糖醇类,能通过增加胰岛素受体数量来提高胰岛素与受体结合的敏感性,促进组织摄取葡萄糖从而降低糖尿病患者的血糖值;多聚果糖作为一种不溶性的膳食纤维,具有促进肠道蠕动,缩短了食物在肠内的通过时间,增加了粪便体积,延缓了葡萄糖吸收速率,并减慢了淀粉的水解速度,这些效应对改善胃肠道功能均具有积极的作用,可以减轻便秘给糖尿病人造成的痛苦;L-阿拉伯糖能抑制淀粉转变成葡萄糖,阻断葡萄糖的生成;魔芋粉能形成高黏度的水溶物,能有效延缓人体小肠壁对糖类的吸收速率。The hypoglycemic health-care flour provided by the invention uses conventional flour as a carrier, is equipped with miscellaneous grain ingredients such as oat flour, buckwheat flour, and konjac flour, and is supplemented with polyfructose and L-arabinose components, so that the obtained hypoglycemic flour has a mouthfeel Well, it is safe and can provide a certain amount of energy. In this flour, oat flour is rich in soluble β-glucan, which can improve glucose tolerance and reduce the degree of starch hydrolysis by α-amylase; it can wrap starch molecules, affect the structure of protein-starch matrix, and reduce the The interaction between starch hydrolytic enzymes and starch substrate molecules; buckwheat flour contains a certain amount of resistant starch, which is not absorbed by the small intestine, but is fermented in the large intestine, causing the slow release of glucose; its Cr 3+ content is rich , constitute the glucose tolerance factor, which can enhance the function of insulin; at the same time, the buckwheat component can also act as a glucosidase inhibitor, and its composition contains a certain amount of sugar alcohols, which can increase the number of insulin receptors to increase the insulin resistance. The sensitivity of binding to receptors promotes the uptake of glucose by tissues and reduces the blood sugar level of diabetic patients; as an insoluble dietary fiber, polyfructose can promote intestinal peristalsis, shorten the passage time of food in the intestine, and increase the stool L-arabinose can delay the absorption rate of glucose and slow down the hydrolysis rate of starch. These effects have a positive effect on improving gastrointestinal function and can relieve the pain caused by constipation to diabetics; L-arabinose can inhibit the conversion of starch into Glucose, blocking the production of glucose; konjac flour can form high-viscosity water-soluble substances, which can effectively delay the absorption rate of carbohydrates by the human small intestine wall.
本发明提供的降糖保健面粉,在保证口感、安全和提供一定能量的基础上,在小麦粉为载体上添加的燕麦粉、荞麦粉、多聚果糖、L-阿拉伯糖和魔芋粉在降血糖方面具有相互协同效应和倍增效果,从提高葡萄糖耐量,增强胰岛素的功能,抑制淀粉转变成葡萄糖,延缓人体小肠壁对糖类的吸收速率,促进肠道蠕动、减慢淀粉的水解速度等多个方面降低糖尿病患者餐后血糖水平,减少高血糖对其身体造成的伤害。The hypoglycemic health-care flour provided by the invention, on the basis of ensuring mouthfeel, safety and providing a certain amount of energy, oat flour, buckwheat flour, polyfructose, L-arabinose and konjac powder added on the carrier of wheat flour can reduce blood sugar. It has a mutual synergistic effect and a multiplier effect, from improving glucose tolerance, enhancing insulin function, inhibiting the conversion of starch into glucose, delaying the absorption rate of carbohydrates by the human small intestine wall, promoting intestinal peristalsis, slowing down the hydrolysis rate of starch, etc. Reduce the postprandial blood sugar level of diabetic patients and reduce the damage caused by high blood sugar to their bodies.
所述小麦粉可以为市场上的常规面粉或精制面粉。The wheat flour can be conventional flour or refined flour on the market.
所述荞麦粉优选为苦荞麦粉。荞麦粉可以为甜荞麦粉或苦荞麦粉,苦荞麦的药用功效高于普通荞麦,使用苦荞麦粉具有更好的降血糖效果。The buckwheat flour is preferably tartary buckwheat flour. The buckwheat flour can be sweet buckwheat flour or tartary buckwheat flour. The medicinal efficacy of tartary buckwheat is higher than that of ordinary buckwheat, and the use of tartary buckwheat flour has better hypoglycemic effect.
所述魔芋粉优选为魔芋纯化粉。魔芋纯化粉是以魔芋粉为原料,以食用酒精为载体,经过多次浸泡提纯后除去魔芋粉中灰分、纤维素、色素、生物碱等成分,使葡甘聚糖的纯度更高,有利于生成高黏度的水溶物,能有效延缓人体小肠壁对糖类的吸收速率。The konjac flour is preferably purified konjac flour. Konjac purified powder is made of konjac flour, with edible alcohol as the carrier. After repeated soaking and purification, the ash, cellulose, pigment, alkaloid and other components in the konjac flour are removed, so that the purity of glucomannan is higher, which is beneficial to The formation of high-viscosity water-soluble substances can effectively delay the absorption rate of carbohydrates in the small intestine wall of the human body.
上述降糖保健面粉的制备方法,包括:将燕麦粉、荞麦粉、多聚果糖、L-阿拉伯糖和魔芋粉混合后加水,在85~95℃下搅拌熟化,喷雾干燥,过筛即得杂粮混合粉;将杂粮混合粉与小麦粉混合均匀,即可。The preparation method of the above-mentioned hypoglycemic health-care flour includes: mixing oat flour, buckwheat flour, polyfructose, L-arabinose and konjac flour, adding water, stirring and aging at 85-95°C, spray drying, and sieving to obtain miscellaneous grains Mixed flour; mix the multigrain mixed flour and wheat flour evenly.
优选的,将燕麦粉、荞麦粉、多聚果糖、L-阿拉伯糖和魔芋粉分别过60目筛,再将各原料粉混合后加水。Preferably, oat flour, buckwheat flour, polyfructose, L-arabinose and konjac flour are respectively passed through a 60-mesh sieve, and then the raw material powders are mixed and then added with water.
所述荞麦粉为苦荞麦粉。The buckwheat flour is tartary buckwheat flour.
所述魔芋粉为魔芋纯化粉。The konjac powder is purified konjac powder.
所述加水的质量为燕麦粉、荞麦粉、多聚果糖、L-阿拉伯糖和魔芋粉混合后总质量的15~25倍。The mass of the added water is 15 to 25 times of the total mass of the mixed oat flour, buckwheat flour, polyfructose, L-arabinose and konjac flour.
所述熟化的时间为1~1.5h。所述过筛所用的筛网为120目。The aging time is 1-1.5 hours. The screen used for the sieving is 120 mesh.
本发明所提供的制备方法,将燕麦粉、荞麦粉、多聚果糖、L-阿拉伯糖和魔芋粉等组分加水熟化后,经过喷雾干燥再与小麦粉简单混合即可制成,整个制备过程简单紧凑,所得面粉质量稳定性好,适于大规模推广应用。The preparation method provided by the present invention can be made by adding water and aging components such as oat flour, buckwheat flour, polyfructose, L-arabinose and konjac flour, and then simply mixing them with wheat flour after spray drying. The whole preparation process is simple The flour is compact, the quality of the obtained flour is stable, and it is suitable for large-scale popularization and application.
具体实施方式detailed description
下面结合具体实施例对本发明作进一步说明。The present invention will be further described below in conjunction with specific examples.
实施例1Example 1
本实施例的降糖保健面粉,主要由以下质量份的组分组成:精制面粉80份,燕麦粉15份,苦荞麦粉6份,多聚果糖3份,L-阿拉伯糖2份,魔芋纯化粉1.5份。The hypoglycemic health-care flour of this embodiment is mainly composed of the following components by mass: 80 parts of refined flour, 15 parts of oat flour, 6 parts of tartary buckwheat flour, 3 parts of polyfructose, 2 parts of L-arabinose, purified konjac Powder 1.5 parts.
本实施例的降糖保健面粉的制备方法,包括:将燕麦粉、苦荞麦粉、多聚果糖、L-阿拉伯糖和魔芋纯化粉过60目筛,混合后加入总质量20倍的水,在85℃下搅拌熟化1h,喷雾干燥,过120目筛即得杂粮混合粉;将杂粮混合粉与精制面粉在混合器中混合20min,即得。The preparation method of the hypoglycemic health-care flour of the present embodiment includes: passing oat flour, tartary buckwheat flour, polyfructose, L-arabinose and konjac purified powder through a 60-mesh sieve, adding 20 times the total mass of water after mixing, and Stir and mature at 85°C for 1 hour, spray dry, and pass through a 120-mesh sieve to obtain the mixed grain powder; mix the mixed grain powder and refined flour in a mixer for 20 minutes to obtain the product.
实施例2Example 2
本实施例的降糖保健面粉,主要由以下质量份的组分组成:精制面粉95份,燕麦粉8份,苦荞麦粉4份,多聚果糖3份,L-阿拉伯糖4份,魔芋纯化粉0.5份。The hypoglycemic health-care flour of this embodiment is mainly composed of the following components by mass: 95 parts of refined flour, 8 parts of oat flour, 4 parts of tartary buckwheat flour, 3 parts of polyfructose, 4 parts of L-arabinose, purified konjac Powder 0.5 part.
本实施例的降糖保健面粉的制备方法,包括:将燕麦粉、苦荞麦粉、多聚果糖、L-阿拉伯糖和魔芋纯化粉过60目筛,混合后加入总质量25倍的水,在95℃下搅拌熟化1h,喷雾干燥,过120目筛即得杂粮混合粉;将杂粮混合粉与精制面粉在混合器中混合30min,即得。The preparation method of the hypoglycemic health-care flour of the present embodiment includes: passing oat flour, tartary buckwheat flour, polyfructose, L-arabinose and konjac purified powder through a 60-mesh sieve, adding 25 times the total mass of water after mixing, and Stir and mature at 95°C for 1 hour, spray dry, and pass through a 120-mesh sieve to obtain the mixed grain powder; mix the mixed grain powder and refined flour in a mixer for 30 minutes to obtain the product.
实施例3Example 3
本实施例的降糖保健面粉,主要由以下质量份的组分组成:精制面粉90份,燕麦粉8份,苦荞麦粉5份,多聚果糖6份,L-阿拉伯糖3份,魔芋纯化粉0.5份。The hypoglycemic health-care flour of this embodiment is mainly composed of the following components by mass: 90 parts of refined flour, 8 parts of oat flour, 5 parts of tartary buckwheat flour, 6 parts of polyfructose, 3 parts of L-arabinose, purified konjac Powder 0.5 part.
本实施例的降糖保健面粉的制备方法,包括:将燕麦粉、苦荞麦粉、多聚果糖、L-阿拉伯糖和魔芋纯化粉过60目筛,混合后加入总质量15倍的水,在90℃下搅拌熟化1.5h,喷雾干燥,过120目筛即得杂粮混合粉;将杂粮混合粉与精制面粉在混合器中混合30min,即得。The preparation method of the hypoglycemic health-care flour of the present embodiment includes: passing oat flour, tartary buckwheat flour, polyfructose, L-arabinose and konjac purified powder through a 60-mesh sieve, adding 15 times the total mass of water after mixing, and Stir and mature at 90°C for 1.5 hours, spray dry, pass through a 120-mesh sieve to obtain mixed grain powder; mix the mixed grain powder and refined flour in a mixer for 30 minutes to obtain the product.
实施例4Example 4
本实施例的降糖保健面粉,主要由以下质量份的组分组成:精制面粉87份,燕麦粉12份,苦荞麦粉4.5份,多聚果糖4.8份,L-阿拉伯糖4.5份,魔芋纯化粉0.8份。The hypoglycemic health-care flour of this embodiment is mainly composed of the following components by mass: 87 parts of refined flour, 12 parts of oat flour, 4.5 parts of tartary buckwheat flour, 4.8 parts of polyfructose, 4.5 parts of L-arabinose, purified konjac Powder 0.8 part.
本实施例的降糖保健面粉的制备方法,包括:将燕麦粉、苦荞麦粉、多聚果糖、L-阿拉伯糖和魔芋纯化粉过60目筛,混合后加入总质量20倍的水,在90℃下搅拌熟化1h,喷雾干燥,过120目筛即得杂粮混合粉;将杂粮混合粉与精制面粉在混合器中混合30min,即得。The preparation method of the hypoglycemic health-care flour of the present embodiment includes: passing oat flour, tartary buckwheat flour, polyfructose, L-arabinose and konjac purified powder through a 60-mesh sieve, adding 20 times the total mass of water after mixing, and Stir and ripen at 90°C for 1 hour, spray dry, pass through a 120-mesh sieve to obtain the mixed grain powder; mix the mixed grain powder and refined flour in a mixer for 30 minutes to obtain the product.
试验例Test case
将本发明实施例1~4所得降血糖面粉与面粉+燕麦粉、面粉+苦荞麦粉、面粉+多聚果糖、面粉+L-阿拉伯糖、面粉+魔芋纯化粉进行降血糖效果试验测试。降血糖效果试验方法依据卫生部《保健食品功能学评价程序》,将各实施例所得降血糖面粉、面粉+燕麦粉(质量按各实施例中混合面粉配方中燕麦粉所占质量最大百分比例计算称取)、面粉+苦荞麦粉(质量按各实施例中混合面粉配方中苦荞麦粉所占质量最大百分比计算称取)、面粉+多聚果糖(质量按各实施例中混合面粉配方中多聚果糖所占质量最大百分比计算称取)、面粉+L-阿拉伯糖(质量按各实施例中混合面粉配方中L-阿拉伯糖所占质量最大百分比计算称取)、面粉+魔芋纯化粉(质量按各实施例中混合面粉配方中魔芋纯化粉所占质量最大百分比计算称取),通过建立大鼠四氧嘧啶糖尿病模型,在同一剂量下,比较其对糖尿病的治疗效果。The hypoglycemic flour obtained in Examples 1 to 4 of the present invention, flour + oat flour, flour + tartary buckwheat flour, flour + polyfructose, flour + L-arabinose, and flour + konjac purified powder were tested for their hypoglycemic effect. Hypoglycemic effect test method is according to Ministry of Public Health " health food functional evaluation procedure ", with each embodiment gained hypoglycemic flour, flour+oat flour (quality is accounted for mass maximum percentage example calculation of oat flour in the mixed flour formula in each embodiment Weighing), flour+tartary buckwheat flour (the quality is calculated and weighed according to the maximum mass percentage of tartary buckwheat flour in the mixed flour formula in each embodiment), flour+polyfructose (the quality is weighed by the mixed flour formula in each embodiment) Polyfructose accounted for the mass percentage of the maximum percentage calculation and weighing), flour+L-arabinose (quality is calculated and weighed according to the maximum mass percentage of L-arabinose in the mixed flour formula in each embodiment), flour+konjac purified powder (mass Calculate and weigh according to the maximum mass percentage of konjac purified powder in the mixed flour formula in each embodiment), and compare its therapeutic effect on diabetes by establishing a rat alloxan diabetes model at the same dose.
将实验性糖尿病大鼠随机分成11组,即空白对照组、阳性对照组和9个试验组。单笼饲养,饮水、饲料采取渐加、渐减的办法,以次日几乎无剩余为度,适应4d。从第5日起,每日上午定时在测量血糖后灌胃。其中试验组剂量2.5g/(kg·d),对照组生理盐水3ml/(kg·d),阳性对照盐酸二甲双胍片125mg/(kg·d),试验期限21d。降血糖效果如表1所示。The experimental diabetic rats were randomly divided into 11 groups, namely blank control group, positive control group and 9 test groups. Breeding in single cages, drinking water and feed are gradually increased and decreased, and the next day there is almost no surplus, and they are adapted for 4 days. From the 5th day onwards, the blood sugar was measured regularly every morning and gavage. Among them, the dosage of the test group was 2.5g/(kg·d), the normal saline of the control group was 3ml/(kg·d), the positive control metformin hydrochloride tablet was 125mg/(kg·d), and the test period was 21 days. The hypoglycemic effect is shown in Table 1.
表1不同配方面粉对糖尿病大鼠降血糖效果的比较Table 1 Comparison of different formula flours on hypoglycemic effects in diabetic rats
由表1的试验结果可知,实施例1~4的降血糖面粉相比面粉+燕麦粉、面粉+苦荞麦粉、面粉+多聚果糖、面粉+L-阿拉伯糖、面粉+魔芋纯化粉的降血糖效果显著,大鼠血糖浓度较糖尿病模型组最大降低百分数达37.88%。As can be seen from the test results in Table 1, the blood sugar-lowering flours of Examples 1-4 are compared with flour+oat flour, flour+tartary buckwheat flour, flour+polyfructose, flour+L-arabinose, flour+konjac purified powder. The blood sugar effect is remarkable, and the maximum reduction percentage of the blood sugar concentration of rats is 37.88% compared with the diabetes model group.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510628790.2A CN105341641A (en) | 2015-09-28 | 2015-09-28 | Health-care flour capable of reducing blood sugar and preparation method of health-care flour |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510628790.2A CN105341641A (en) | 2015-09-28 | 2015-09-28 | Health-care flour capable of reducing blood sugar and preparation method of health-care flour |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105341641A true CN105341641A (en) | 2016-02-24 |
Family
ID=55317919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510628790.2A Pending CN105341641A (en) | 2015-09-28 | 2015-09-28 | Health-care flour capable of reducing blood sugar and preparation method of health-care flour |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105341641A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105558787A (en) * | 2016-03-04 | 2016-05-11 | 山东省农业科学院 | Health-care flour for diabetic patients and preparation method thereof |
CN106418140A (en) * | 2016-08-23 | 2017-02-22 | 济南东旭食品有限公司 | Tartary buckwheat and lotus leaf healthy flour and product thereof |
CN107467492A (en) * | 2017-08-08 | 2017-12-15 | 合肥康桥工贸有限公司 | A kind of saccharide-controlled wheat flour |
CN107836640A (en) * | 2017-11-30 | 2018-03-27 | 迈纽斯(苏州)生物科技有限公司 | A kind of high-fiber high-protein alimentary paste and preparation method thereof |
CN108477262A (en) * | 2018-06-08 | 2018-09-04 | 益家元品实业(厦门)有限公司 | Premixed powder and preparation method thereof |
CN110384207A (en) * | 2019-07-23 | 2019-10-29 | 华南农业大学 | A kind of konjaku coarse cereals recombination rice and preparation method thereof conducive to glycaemic homeostasis |
CN110403127A (en) * | 2019-08-19 | 2019-11-05 | 王红艺 | A kind of hypoglycemic flour |
CN114431393A (en) * | 2020-11-06 | 2022-05-06 | 北京大学 | Compound coarse cereals with glycolipid metabolism regulating function |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1185908A (en) * | 1996-12-27 | 1998-07-01 | 李江 | Functional cordyceps sinensis milk, products made from cordyceps sinensis milk and preparation thereof |
CN1466882A (en) * | 2002-07-11 | 2004-01-14 | 侯书良 | Resistant starch health flour |
CN102177934A (en) * | 2011-03-26 | 2011-09-14 | 赵文全 | Low-glucogenic flour |
CN102406860A (en) * | 2010-09-25 | 2012-04-11 | 北京信安康生物科技有限公司 | Composition for preventing and treating diabetes, preparation method and application thereof |
CN102626120A (en) * | 2012-05-15 | 2012-08-08 | 安徽燕之坊食品有限公司 | Coarse-cereal food flour |
CN102805296A (en) * | 2012-07-27 | 2012-12-05 | 安徽四海食品有限公司 | Blood-sugar-reducing health-care noodles and preparation method thereof |
CN102960387A (en) * | 2012-11-10 | 2013-03-13 | 王萍 | Health-care flour for diabetic patients |
CN103285231A (en) * | 2013-05-13 | 2013-09-11 | 刘扬 | Medicine composition for diabetes adjunctive therapy and preparation method thereof |
CN103829140A (en) * | 2014-03-25 | 2014-06-04 | 张立芬 | Cereal powder with functions of losing weight and reducing blood sugar |
CN103976365A (en) * | 2014-04-16 | 2014-08-13 | 安徽玉龙制面食品有限责任公司 | Dandelion blood sugar lowering health noodles and preparation method thereof |
CN104187670A (en) * | 2014-09-02 | 2014-12-10 | 高鹏 | Special dietary formula for assisting patients with diabetes in regulating blood sugar |
-
2015
- 2015-09-28 CN CN201510628790.2A patent/CN105341641A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1185908A (en) * | 1996-12-27 | 1998-07-01 | 李江 | Functional cordyceps sinensis milk, products made from cordyceps sinensis milk and preparation thereof |
CN1466882A (en) * | 2002-07-11 | 2004-01-14 | 侯书良 | Resistant starch health flour |
CN102406860A (en) * | 2010-09-25 | 2012-04-11 | 北京信安康生物科技有限公司 | Composition for preventing and treating diabetes, preparation method and application thereof |
CN102177934A (en) * | 2011-03-26 | 2011-09-14 | 赵文全 | Low-glucogenic flour |
CN102626120A (en) * | 2012-05-15 | 2012-08-08 | 安徽燕之坊食品有限公司 | Coarse-cereal food flour |
CN102805296A (en) * | 2012-07-27 | 2012-12-05 | 安徽四海食品有限公司 | Blood-sugar-reducing health-care noodles and preparation method thereof |
CN102960387A (en) * | 2012-11-10 | 2013-03-13 | 王萍 | Health-care flour for diabetic patients |
CN103285231A (en) * | 2013-05-13 | 2013-09-11 | 刘扬 | Medicine composition for diabetes adjunctive therapy and preparation method thereof |
CN103829140A (en) * | 2014-03-25 | 2014-06-04 | 张立芬 | Cereal powder with functions of losing weight and reducing blood sugar |
CN103976365A (en) * | 2014-04-16 | 2014-08-13 | 安徽玉龙制面食品有限责任公司 | Dandelion blood sugar lowering health noodles and preparation method thereof |
CN104187670A (en) * | 2014-09-02 | 2014-12-10 | 高鹏 | Special dietary formula for assisting patients with diabetes in regulating blood sugar |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105558787A (en) * | 2016-03-04 | 2016-05-11 | 山东省农业科学院 | Health-care flour for diabetic patients and preparation method thereof |
CN106418140A (en) * | 2016-08-23 | 2017-02-22 | 济南东旭食品有限公司 | Tartary buckwheat and lotus leaf healthy flour and product thereof |
CN107467492A (en) * | 2017-08-08 | 2017-12-15 | 合肥康桥工贸有限公司 | A kind of saccharide-controlled wheat flour |
CN107836640A (en) * | 2017-11-30 | 2018-03-27 | 迈纽斯(苏州)生物科技有限公司 | A kind of high-fiber high-protein alimentary paste and preparation method thereof |
CN108477262A (en) * | 2018-06-08 | 2018-09-04 | 益家元品实业(厦门)有限公司 | Premixed powder and preparation method thereof |
CN108477262B (en) * | 2018-06-08 | 2021-09-24 | 唐传生物科技(厦门)有限公司 | Premixed flour and preparation method thereof |
CN110384207A (en) * | 2019-07-23 | 2019-10-29 | 华南农业大学 | A kind of konjaku coarse cereals recombination rice and preparation method thereof conducive to glycaemic homeostasis |
CN110403127A (en) * | 2019-08-19 | 2019-11-05 | 王红艺 | A kind of hypoglycemic flour |
CN114431393A (en) * | 2020-11-06 | 2022-05-06 | 北京大学 | Compound coarse cereals with glycolipid metabolism regulating function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105341641A (en) | Health-care flour capable of reducing blood sugar and preparation method of health-care flour | |
AU2019101804A4 (en) | Traditional Chinese medicine medical nutrition therapy-based composition for treating diabetes, and application | |
CN105211853B (en) | Blood sugar reducing health composition, electuary and preparation method thereof | |
CN100579395C (en) | Instant nutritive gruel having a function of stabilizing body blood sugar after meal and method for preparing the same | |
CN101317666A (en) | High-efficiency composite food cellulose and preparation method thereof | |
CN106666312A (en) | A kind of health food for auxiliary hypoglycemia and its preparation method for granules and capsules | |
CN105211687A (en) | A kind of composition and method of making the same and purposes | |
CN101731622A (en) | Lucid ganoderma spirulina tablet and preparation process thereof | |
CN106360310A (en) | Composition for dropping after meal blood sugar and application thereof | |
CN105105116A (en) | Health food with effects of relieving physical fatigue and enhancing immunity and preparation method of health food | |
CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
CN102204649B (en) | Healthcare food for regulating and stabilizing blood sugar and method for preparing same | |
CN107960508A (en) | A kind of kidney tonifying and dispelling fatigue, the pressed candy for improving sleep | |
CN103156122B (en) | Health-care Astragalus mongholicus porridge and preparation method thereof | |
CN104856059A (en) | Weight-losing health nutrition powder | |
CN102132716A (en) | Special biscuit for patient with diabetes and preparation method thereof | |
CN1879769A (en) | Chinese medicinal preparation capable of increasing poultry immunity | |
CN110574862A (en) | Nutritional weight-losing meal replacement powder suitable for teenagers and children and preparation method thereof | |
CN107897931A (en) | Meal replacement powder for nourishing the stomach control energy and preparation method thereof | |
CN101416743B (en) | Potentilla anserina L. rice flour food and production method thereof | |
CN108185441A (en) | A kind of formula food for treating diabetes and preparation method thereof | |
CN106465946A (en) | A kind of loosening bowel to relieve constipation dietary fiber | |
CN102150779B (en) | Health food for regulating and stabilizing blood sugar and preparation method thereof | |
CN107549614A (en) | Three high meals powder and preparation method thereof are nursed one's health in a kind of dietotherapy | |
CN105535553A (en) | Formula for regulating blood sugar of human body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |
|
RJ01 | Rejection of invention patent application after publication |